Regency Capital Management Inc. DE Purchases 4,479 Shares of AMETEK, Inc. $AME

Key Points

• Regency Capital Management Inc. DE increased its holdings in AMETEK, Inc. by 15.3%, now owning 33,804 shares valued at approximately $6.12 million, making AMETEK the fund's 9th biggest holding.
• AMETEK reported a Q2 earnings per share (EPS) of $1.78, exceeding analysts' expectations, and achieved a revenue of $1.78 billion, up 2.5% year-over-year.
• The company has announced a quarterly dividend of $0.31 paid to stockholders, representing a 0.7% dividend yield with a payout ratio of 19.97%.

Regency Capital Management Inc. DE increased its position in shares of AMETEK, Inc. (NYSE:AME - Free Report) by 15.3% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 33,804 shares of the technology company's stock after purchasing an additional 4,479 shares during the quarter. AMETEK accounts for 3.2% of Regency Capital Management Inc. DE's investment portfolio, making the stock its 9th biggest holding. Regency Capital Management Inc. DE's holdings in AMETEK were worth $6,117,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the company. Bares Capital Management Inc. acquired a new position in shares of AMETEK during the 1st quarter worth $26,000. ST Germain D J Co. Inc. raised its position in AMETEK by 628.6% during the second quarter. ST Germain D J Co. Inc. now owns 153 shares of the technology company's stock worth $28,000 after acquiring an additional 132 shares during the last quarter. Olde Wealth Management LLC purchased a new stake in shares of AMETEK in the first quarter valued at about $29,000. Annis Gardner Whiting Capital Advisors LLC grew its position in shares of AMETEK by 57.7% in the first quarter. Annis Gardner Whiting Capital Advisors LLC now owns 194 shares of the technology company's stock valued at $33,000 after purchasing an additional 71 shares during the last quarter. Finally, Zions Bancorporation National Association UT purchased a new position in shares of AMETEK during the 1st quarter worth approximately $42,000. Institutional investors and hedge funds own 87.43% of the company's stock.

AMETEK Price Performance

AME stock opened at $183.19 on Tuesday. The company has a market cap of $42.31 billion, a PE ratio of 29.50, a price-to-earnings-growth ratio of 2.64 and a beta of 1.11. The company has a current ratio of 1.63, a quick ratio of 1.04 and a debt-to-equity ratio of 0.15. The stock has a 50-day moving average price of $185.50 and a two-hundred day moving average price of $177.82. AMETEK, Inc. has a 12-month low of $145.02 and a 12-month high of $198.33.

AMETEK (NYSE:AME - Get Free Report) last issued its earnings results on Thursday, July 31st. The technology company reported $1.78 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.69 by $0.09. The business had revenue of $1.78 billion during the quarter, compared to analysts' expectations of $1.74 billion. AMETEK had a return on equity of 16.53% and a net margin of 20.60%.The company's revenue for the quarter was up 2.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.66 EPS. AMETEK has set its Q3 2025 guidance at 1.720-1.760 EPS. FY 2025 guidance at 7.060-7.200 EPS. As a group, research analysts predict that AMETEK, Inc. will post 7.15 EPS for the current year.

AMETEK Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Monday, September 15th were given a $0.31 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $1.24 annualized dividend and a dividend yield of 0.7%. AMETEK's dividend payout ratio is presently 19.97%.

Analysts Set New Price Targets

A number of research firms recently issued reports on AME. Melius Research raised AMETEK to a "hold" rating in a research note on Monday, July 14th. Mizuho upped their price objective on AMETEK from $212.00 to $225.00 and gave the company an "outperform" rating in a research report on Friday, August 1st. Barclays initiated coverage on AMETEK in a research note on Wednesday, September 10th. They set an "equal weight" rating and a $200.00 price objective on the stock. Weiss Ratings reissued a "buy (b)" rating on shares of AMETEK in a research note on Saturday, September 27th. Finally, Morgan Stanley raised their price target on shares of AMETEK from $185.00 to $198.00 and gave the stock an "equal weight" rating in a research note on Friday, August 8th. Eight investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, AMETEK has an average rating of "Moderate Buy" and a consensus price target of $205.00.

AMETEK Profile

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.